Contents of this document
- Upward revision to the operating profit forecast for Functional Solutions+¥600 million
- Downward revision to the operating profit forecast for Medical-¥800 million
- Upward revision to the operating profit forecast for Apparel+¥200 million
- Apparel business structural improvement costs (prior-year extraordinary income/loss)-¥3,498 million
- Share repurchase (up to 1 million shares and ¥4 billion)
- Promoting the establishment of a resource-circulation model centered on a Circular Factory
- Reduction of Apparel brands and SKUs, site consolidation, and rationalization of indirect functions
- Increasing engineering plastics production and constructing a new plant
| Item | Details |
|---|---|
| Document type | Earnings presentation materials |
| Fiscal Period Covered | Second quarter (interim period) of the fiscal year ending March 2027 |
| Net Sales | ¥64,082 million (YoY -1.8%) |
| Operating profit | ¥5,778 million (YoY +81.3%) |
| Ordinary income | ¥5,843 million (YoY +82.3%) |
| Net income | ¥4,317 million |
| Operating profit margin | 9.0%, 4.9% in the prior-year period, +4.1 percentage points year on year |
| Results for the three months of the current quarter | Net Sales ¥32,714 million (YoY -1.0%) / Operating profit ¥2,391 million (YoY +73.1%) / Ordinary income ¥2,424 million (YoY +77.5%) / Profit attributable to owners of parent for the quarter ¥1,676 million (YoY +105.9%) |
| Full-year earnings forecast | Net Sales ¥132,000 million / Operating profit ¥8,800 million / Ordinary income ¥8,400 million / Profit attributable to owners of the parent ¥5,200 million |
| Self-assessment against the plan | Performance for the current interim consolidated accounting period was broadly within expectations |
| Segment results | Functional Solutions Net Sales ¥26,108 million (YoY +10.3%) / Operating profit ¥5,249 million (YoY +56.9%) / Medical Net Sales ¥6,140 million (YoY -5.3%) / Operating profit ¥709 million (YoY -25.2%) / Apparel Net Sales ¥26,745 million (YoY -10.2%) / Operating profit ¥1,143 million (YoY +358.6%) / Life Create Net Sales ¥5,902 million (YoY +1.1%) / Operating profit ¥606 million (YoY +27.7%) |
| Breakdown of Factors Affecting the Change | Factors Upward revision to the operating profit forecast for Functional Solutions / Amount +¥600 million, Factors Downward revision to the operating profit forecast for Medical / Amount -¥800 million, Factors Upward revision to the operating profit forecast for Apparel / Amount +¥200 million, Factors Apparel business structural improvement costs (prior-year extraordinary income/loss) / Amount -¥3,498 million |
| Financial targets | Equity ratio 71.3 % |
| Annual Dividend | Annual dividend per share ¥147 / Interim and Year-End Breakdown Not disclosed |
| Payout ratio | 130.2 % |
| Acquisition of treasury shares | Number of shares acquired 1,000,000 Shares (maximum) / Acquisition price ¥4,000 millions (upper limit) / Period From 6 November 2026 to 24 March 2027 |
| Capital expenditures | ¥3,813 million (first half) |
| New initiatives | Share repurchase (up to 1 million shares and ¥4 billion), Promoting the establishment of a resource-circulation model centered on a Circular Factory, Reduction of Apparel brands and SKUs, site consolidation, and rationalization of indirect functions, Increasing engineering plastics production and constructing a new plant |
Items this document does not state (13)
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.In plastic films, the time lag between changes in selling prices and raw material prices boosted profit. Improvements in the profitability of the overseas business, product cost improvements in Japan and overseas, and progress in the structural reform of the Apparel business also lifted operating profit. Net sales declined due to lower Apparel sales.